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ABSTRACT  
 
Maxillary sinus augmentation with biphasic calcium phosphate: a 
clinical and radiographic study 
Jae-Kook Cha, D.D.S. 
 
Department of Dental Science 
Graduate School, Yonsei University 
(Directed by Professor Seong-Ho Choi, D.D.S., M.S.D., PhD.) 
 
The aim of this study was to evaluate 3.5 years-cumulative survival rate of implants 
placed on augmented sinus using Osteon
®
, a bone graft material, and to assess the height 
of the grafted material through radiographic evaluation. Twenty patients were treated 
with maxillary sinus augmentation and 45 implant fixtures were installed simultaneously 
or after 6 months healing period. The height of the augmented sinus and the loss of 
marginal bone were measured by panoramic and intraoral radiographs immediately after 
augmentation and up to 42 months (mean 19.4) subsequently. Changes in the height of 
the sinus graft material were calculated radiographically. The cumulative survival rate 
was 95.56% in all 45 implants. Additionally, normal healing process without any 
complication was observed in all patients. The original sinus height was mean 4.3 mm 
and the augmented sinus height was mean 13.4 mm after the surgery. The mean marginal 
bone loss till 42 months was 0.52±0.56mm. The reduced height of Osteon
®  
was 
0.83±0.38 mm and it did not show significant correlation with the follow up periods 
(P=0.102). There were no statistically significant differences in reduced height of 
Osteon
®
 according to the simultaneous/delayed implantation (P=0.299) and particle size 
of Osteon
®
 (P=0.644). It can be suggested that Osteon
®
 may have predictable result when 
it was used as a grafting material for sinus floor augmentation. 
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clinical and radiographic study 
Jae-Kook Cha, D.D.S. 
 
Department of Dental Science 
Graduate School, Yonsei University 
(Directed by Professor Seong-Ho Choi, D.D.S., M.S.D., PhD.) 
 
 
I. Introduction 
One of the necessary requirements for dental implant is to ensure with a moderate 
amount of bone to place an implant with appropriate length and diameter. The loss of 
alveolar ridge due to trauma, periodontal disease, or the failure of endodontic treatment, 
however, may make it difficult to place the implant on ideal place with proper esthetics 
and function. Especially in the maxillary posterior area, it is known to be difficult and to 
have a low success rate because of the poor bone quality. Moreover, the posterior 
edentulous maxilla has represented a challenge for clinicians owing to the resorption of 
alveolar ridge and pneumatization of maxillary sinus. 
This has led to the development of bone augmentation technique, the onlay bone graft 
and the sinus augmentation. Sinus augmentation via lateral window osteotomy has been 
routinely performed in the last few years and has been regarded as a predictable 
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procedure (Chiapasco et al., 2008; Jensen et al., 1998; Pjetursson et al., 2008; Wallace 
and Froum, 2003). However, the choice of the bone graft material is still under discussion.  
The use of autogenous bone in sinus augmentation has been regarded as a superior 
method because in that reproducible healing mechanism of osteogenesis, osteoinduction, 
and osteoconduction. Nevertheless, there are some limitations e.g. the needs of additional 
surgical sites and rapid resorption rate when the autogenous bone was used as a sinus 
grafting material (Hallman et al., 2002; Johansson et al., 2001; Misch and Dietsh, 1993). 
Therefore, the use of synthetic bone has been recently appraised for its biocompatibility 
and volume maintenance capacity (Dalkyz et al., 2000; Kim et al., 2009). 
Various synthetic materials have been developed for use in maxillary sinus 
augmentation to allow bone ingrowth and to prevent sinus pneumatization after grafting. 
Among them, the mixture of hydroxiapitite (HA) and beta-tricalcium phosphate (β-TCP) 
has been studied vigorously as a new alloplastic material (Daculsi et al., 1989). The HA 
can play an osteoconductive role due to its appropriate space maintenance capacity, but 
has low osteogenetic property. While β-TCP, with its good biocompatibility, has been 
used as a substitute of autogenous bone (Gauthier et al., 1998; Karabuda et al., 2001). In 
this point of view, mixing adequate ratios of HA and β-TCP allowed to control the 
resorption rate without distorting its osteoconductive property (Nery et al., 1992; Yamada 
et al., 1997a, 1997b).   
Osteon
®
 (Dentium, Seoul, Korea) is synthetic material containing 70% HA and 30% 
β-TCP. It has a porous structure which can accelerate new bone ingrowth and maturation 
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(Fig. 1). Two different particle sizes of Osteon
®  
have been used (0.5-1.0 mm and 1.0-2.0 
mm). In several previous studies, Osteon
®
 was regarded as a suitable sinus augmentation 
material based on the histologic analysis (Kim et al., 2008).
 
Moreover, we have 
precedingly reported that the volume maintenance of grafted Osteon
®  
and implant success 
rate as a pilot study (Cha et al., 2010). In that study, the grafted material was well 
maintained in sinus and decreased slightly over 1 year (0.05 mm/month). It can be 
suggested that Osteon
®
 may have predictable result when it was used as a grafting 
material for sinus floor augmentation. 
The aim of the present study was to evaluate cumulative survival rate (CSR) of 
implants placed on augmented sinus using Osteon
®
, and to assess resorption rate of the 
grafted material radiographically with increased sample size and statistical power as an 
extension of our previous studies. 
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II. Material and methods 
 
This study was approved by the Institutional Review Board of Yonsei University 
College of Dentistry (Approval No. 5-2008-3). A total 45 implants were placed in 20 
maxillary sinuses of 20 patients (8 males, 12 females, mean age 57.2±11.3 years) with the 
condition of having under 5mm of residual alveolar bone height, using sinus 
augmentation technique via lateral window osteotomy (Zitzmann and Scharer, 1998). All 
implants were maintained with at least 6 months of prosthetic loading time. Patients’ 
exclusion criteria were: (1) heavy smoker (more than 20 cigarettes per day), (2) 
debilitating systemic disease like uncontrolled diabetic mellitus (3) sign and symptom of 
maxillary sinus disease (4) active periodontal disease involving the residual dentition. 
Five implants were from Branemark System-MKIII TiUnite (NobelBiocare, Gotenborg, 
Sweden); 12 implants were from Xive (Dentsply Friadent, Mannheim, Germany), 5 
implants were from Astra (Astra Tech, Mölndal, Sweden), 6 implants were from Osstem 
GSII (Osstem implants, Busan, Korea), 17 implants were from Implantium (Dentium, 
Seoul, Korea). All implants were placed in either 1 or 2 stage surgery. The timing of 
implantation was determined, depending on the primary stabilization of implants. In the 2 
stage approach, implantation was performed 6 months after the augmentation of the 
maxillary sinus. 
Mixture of 2 different types of Osteon
®
 in a 1:1 ratio was used in 10 patients, while 
only larger particle size of Osteon
®
 was used in the other 10 patients. The quality of bone 
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was evaluated according to the Lekholm and Zarb’s classification during the surgical 
procedure (Zarb and Zarb, 1985). Most of the examined subsinus ridges were composed 
of bone with poor quality (type III and IV). The general information of cases is presented 
in Table 1. 
 
 
1. Surgical technique 
 
A modified Caldwell-Luc sinus augmentation was performed under local anesthesia 
(2% lidocaine hydrochloride–epinephrine 1:100,000, Kwangmyung Pharmaceutical) 
(Boyne and James, 1980; Kent and Block, 1989). In brief, the surgical area was prepared 
via elevation of full thickness muco-periosteal flap. Osteotomy was performed at the 
lateral surface of the sinus wall using diamond round bur and piezoelectric device 
(Piezosurgery, Mectron, Carasco, Italy) and the sinus membrane was carefully lifted. The 
sinus cavity was then packed with Osteon
®
, and the lateral window was covered by an 
absorbable sponge (Collatape
®
, Zimmer dental, USA). The muco-periosteal flap was 
repositioned and sutured with absorbable suture material (Monosyn 4.0 Glyconate 
Monofilament, B. Braun Tuttlingen, Germany), (Vicryl 5.0 Polylactim, Johnson and 
Johnson, U.S.A). The prosthodontic procedure was completed after a mean healing 
period of 6-12 months. 
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2. Implant survival rate 
 
The 42 months CSR for implants was evaluated using life table analysis (Cutler and 
Ederer, 1958). The success criteria for implants presented by Buser et al. was used (Buser 
et al., 1990). 
 
3. Radiographic analysis 
 
The radiographic analysis was performed by panoramic radiographs and intraoral 
radiographs using software (Starpacs® , Infinitt, Seoul, Korea). All the values were 
calibrated precisely based on the length of implant fixture and these were undertaken 
double check by a single investigator. At least 2 consecutive panoramic radiographs were 
taken one immediately after the sinus augmentation, the other 1 year after the surgery. 
Additional radiographs were obtained every 6 to 12 months through the follow up 
protocol. The linear measurements taken from radiographs were described below (Hatano 
et al., 2004), (Fig. 2). The origianl alveolar bone heights (OAH) prior to the surgery 
(Block et al., 1998), from the alveolar crest to the base of sinus were measured (Table 1). 
The augmented sinus heights (ASH) were measured from the 1
st
 bone to implant contact 
points to the base of the maxillary sinus, which was elevated with Osteon
®
 at mesial and 
distal aspects of implants. The volume of marginal bone loss (MBL) was obtained 
compared with the intraoral radiographs immediately taken after the surgery and 1 year 
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postoperatively. The reduced height of Osteon
®  
(RHO) was calculated based on the 
change of ASH and MBL. 
 
4. Statistical analysis 
 
Individual mean values were calculated. Differences in RHO according to the timing of 
implantation and the type of Osteon
®
 were analyzed using the independent t-test. A one 
way analysis of variance was used to evaluate the difference of RHO
 
according to the 
implant sites. The post-hoc Scheffe test was used to evaluate the differences between 
groups. A P value of <0.05 was considered significant. Correlation between the RHO
 
and 
follow up period were determined by Spearman’s test. SPSS version 12.0.0 (LeadTech, 
Chicago, IL, U.S.A) was used for all of the statistical analysis. 
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III. Results 
 
1. Implant survival rate  
 
No complications including wound dehiscence, sinus membrane perforation were 
observed in all patients. 2 of the 45 implants were removed between implantation and the 
follow up period (case 2, I16, 17). All loss of implants was occurred prior to prosthetic 
loading. Both were successfully restored by wider diameter implants. The 0 to 6 month 
CSR was 95.56% and this value continues to 42 months (Table 2). 
 
2. Radiographic analysis 
 
The mean follow up period of implants after the sinus augmentation was 19.4 months 
(range: 12-42 months). The original sinus height was mean 4.3 mm (range: 2.5-5.8 mm) 
and the augmented sinus height was mean 13.4 mm (range: 9.81-18.1 mm) after the 
surgery. The mean crown/implant ratio was 1.19±0.24 mm which was relatively higher 
than natural molar. The marginal bone loss till 12 months was measured 0.29±0.42 mm 
and till 42 months 0.52±0.56 mm. The RHO
 
in 1-year postoperatively
 
was 0.83±0.38 mm, 
in 42 months postoperatively was 0.88±0.39 mm (Table 3).  No significant correlation 
was noted between the RHO and follow up periods by Spearman’s test (P=0.102). There 
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were no statistically significant differences in reduced height of Osteon
®
 according to the 
simultaneous/delayed implantation (P=0.299; Table 4) and particle size of Osteon
®
 
(P=0.644; Table 5). In addition, no significant difference in the RHO was observed 
following the site of implantation (P=0.527; Table 6). 
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IV. Discussion 
 
An ideal material for maxillary sinus augmentation should provide biocompatibility to 
allow bone ingrowth and space maintaining property to prevent sinus pneumatization 
(Block et al., 1998). In the results of present study, the grafted Osteon
®
 was well 
maintained in sinus and decreased slightly over 3.5 years of time period demonstrating 
that it is a clinically suitable material for sinus augmentation.  
Some volumetric loss of grafted material is unavoidable because of the air pressure 
from respiration in the maxillary sinus regardless of the type of material used (Chanavaz, 
1990; Chanavaz et al., 1990; Jensen et al., 1998). Therefore, the change in the height of 
grafted material is an important factor for implant stability.  
Previous studies about the loss of grafted material have been controversial. Hatano et al. 
used autogenous bone and xenogenous bone mixed at a ratio of 2:1 for sinus 
augmentation with simultaneous implant placement and evaluated the resorption rate 
(Hatano et al., 2004). They reported that a statistically significant resorption was occurred 
after 2-3 years, and the maxillary sinus floor was observed at the similar or slightly below 
level of the implant apex. On the other hand, Maiorana et al. evaluated the resorption rate 
after 4 years of maxillary sinus augmentation using synthetic bone graft material 
(hydroxyapatite and collagen). The survival of implant was 97% and the grafted material 
remained steady showing 0.5-1 mm resorption height (Maiorana et al., 2006). Generally, 
it was reported that the resorption rate is influenced by the various kind of graft materials 
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(Jensen et al., 1998). The resorption rate was 1.76 mm in autograft, 2.09 mm in allograft 
(free-dried demineralized bone), and 0.96 mm in alloplast (hydroxyapitite).  
The maxillary sinus cavity is a kind of contained defect surrounded by sinus basal bone 
and the schneiderin membrane, thus it has excellent healing potential even without bone 
graft materials. In this point of view, the long-lasting synthetic and xenogenic bone 
materials are considered to be better choice in terms of the material resorption.  
Two out of 45 implants were removed in this study before prosthetic loading, so it can 
be regarded as an early failure. It seems that excessive hematoma causes the formation of 
exuberant granulation tissue which can be detrimental to initial osseointegration. The 
overall CSR was 95.56% and this result was comparable with other studies despite the 
small sample size (Chiapasco et al., 2008; Jensen et al., 1998; Pjetursson et al., 2008; 
Wallace and Froum, 2003). 
The reduced volume of the Osteon
®  
was increased compared to our previous report 
(0.48 mm resorption in 13 months) (Cha, 2010). No significant difference of the reduced 
volume of the Osteon
®  
was observed according to the timing of implantation. From our 
previous studies, it was reported that the largest amount of Osteon
®  
resorption occurred in 
the 1
st
 molar area and the augmented sinus membrane was changed from a convex shape 
to a flat shape. In this study, however, there was no correlation between the area of the 
implantation and the resorption rate. 
Interestingly, the resorption of Osteon
®  
was occurred regardless of the flow of time. In 
most of other papers, it was found that the graft materials might undergo gradual 
１２ 
 
resorption and pneumatization by time (Hatano et al., 2004; Jensen et al., 1998). Hieu et 
al. radiographically evaluated the changes in height of the xenogenic materials (Bio-Oss
®
, 
Geistlich, OCS-B
®
, Nibec) after maxillary sinus augmentation by 2 years. These studies 
reported that significant material resorption has been taken place depending on the flow 
of time (Hieu et al., 2010). Nonetheless, it could be assumed that many other factors e.g. 
the air pressure in the maxillary sinus, the form of augmented material and the density of 
the grafted material are more important than the time flow. Therefore, it is considered that 
resorption rate of the grafted material is affected by the host’s environment. This would 
be expected to be clarified in the further study. 
Two dimensional Panoramic radiographs have been used to evaluate the grafted 
material and its relationships with implants (Hatano et al., 2004; Kahnberg et al., 2001; 
Keller et al., 1994). Recently, the study utilizing computed-tomography and magnetic 
resonance imaging was reported to assess the grafted sinus floor and this showed more 
accurate results of the volumetric change (Gray et al., 2001). However, in the present 
study, we used only 2-dimensional images, thus further study would be needed through 3-
dimensional images for more accurate volumetric measurement of Osteon
®
.  
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V. CONCLUSION 
 
Within limitation of this study, it can be suggested that Osteon
®
 may have predictable 
result when it was used as a grafting material for sinus floor augmentation since its 
exellent osteoconductive property. 
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Legends 
 
 
Table 1. Case summary.  
 
Table 2. Life table analysis. 
 
Table 3. Radiographic analysis (mean±standard deviation). 
 
Table 4. Differences according to the timing of implantation (mean±standard deviation). 
 
Table 5. Differences according to the type of material (mean± standard deviation). 
 
Table 6. Differences according to the site of implants (mean± standard deviation). 
 
Figure 1. Scanning electron microscope image of Osteon
®  
 
Figure 2. Schematic drawing illustrating the linear measurement taken from radiographs. 
(A) Immediately after the sinus augmentation, (B) 1-year after the sinus augmentation. 
MBL: marginal bone loss, C: crown length, I: implant fixture length, OAH(m): mesial 
original alveolar bone height, OAH(d): distal original alveolar bone height, ASH(m): 
mesial augmented sinus height, ASH(d): distal augmented sinus height. 
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Tables 
 
Table 1. Case summary 
 
Case Age/ Sex Area System Diameter Length 1 or 2 stage Original bone 
height (mm) 
Dose of 
Osteon(cc) 
Type of 
OSteon 
Bone 
quality 
F/U 
(month) 
1 54/F 15 Branemark 4 10.5 simultaneous 4.3  3 S/L IV 30 
  16 Branemark 5 11.5 simultaneous 2.5    IV 30 
2 75/F 15 Branemark 4 11.5 simultaneous 5.0  2.5 S/L III 42 
  16 Branemark 4 11.5 Delayed 2.9    IV 29 
  17 Branemark 4 11.5 Delayed 3.5    IV 29 
3 71/M 26 Implantium 3.8 10 Delayed 5.7  2 S/L III 16 
  27 Implantium 3.8 10 Delayed 2.5    IV 16 
4 64/F 25 Xive 3.4 9.5 Simultaneous 5.5  1.5 S III 18 
  27 Xive 3.8 9.5 Simultaneous 3.2    IV 18 
5 47/F 15 Xive 3.8 9.5 Simultaneous 5.6  1.5 S III 29 
  16 Xive 4.5 9.5 Simultaneous 5.5    III 29 
  17 Xive 4.5 9.5 Simultaneous 3.3    III 29 
6 54/M 16 Implantium 4.3 8 Simultaneous 5.0  2.5 S/L III 19 
  17 Implantium 4.3 8 Simultaneous 3.5    III 19 
7 59/M 26 Implantium 4.8 12 Simultaneous 4.8    III 17 
  27 Implantium 4.8 10 Simultaneous 4.9    III 17 
8 47/F 25 Astra 4 9 Simultaneous 5.8  2 S/L III 18 
  26 Astra 4 9 Simultaneous 4.3    IV 18 
  27 Astra 4 9 Simultaneous 5.4    IV 18 
9 70/M 25 Osstem GSII 4 11.5 Simultaneous 5.6  1.5 S/L III 21 
２１ 
 
 
Case Age/ Sex Area System Diameter Length 1 or 2 stage Original bone 
height (mm) 
Dose of 
Osteon(cc) 
Type of 
OSteon 
Bone 
quality 
F/U 
(month) 
  26 Osstem GSII 4 8.5 Simultaneous 4.0    III 21 
  27 Osstem GSII 4 8.5 Simultaneous 4.7    III 21 
10 77/F 15 Xive 3.4 9.5 Simultaneous 4.5  3 S III 24 
  16 Xive 3.4 9.5 Simultaneous 3.5    III 24 
11 52/F 26 Xive 3.8 9.5 Delayed 3.8  1.5 S III 18 
12 52/F 26 Implantium 4.8 10 Delayed 3.2  1.5 S/L III 15 
  27 Implantium 4.3 10 Delayed 3.4    III 15 
13 55/M 15 Osstem GSII 4 10 Simultaneous 4.8  1.5 S III 20 
  16 Osstem GSII 4 10 Simultaneous 3.7    III 20 
  17 Osstem GSII 4.5 10 Simultaneous 3.6    III 20 
14 41/M 16 Xive 3.8 9.5 Simultaneous 3.8  2 S III 24 
  17 Xive 3.8 9.5 Simultaneous 5.1    III 24 
15 40/M 16 Astra 4 13 Delayed 4.7  2.5 S/L III 17 
  17 Astra 4 13 Delayed 5.7    III 17 
16 45/F 16 Implantium 4.3 10 Delayed 2.5  2.5 S II 12 
  17 Implantium 4.3 10 Delayed 3.7    II 12 
17 58/M 25 Implantium 4.3 8 Simultaneous 4.3  1.5 S IV 12 
  26 Implantium 4.3 8 Simultaneous 4.1    IV 12 
18 74/F 25 Implantium 3.8 8 Simultaneous 5.4  1.5 S III 12 
  26 Implantium 4.3 8 Simultaneous 3.2    III 12 
  27 Implantium 3.8 8 Simultaneous 5.6    III 12 
19 53/F 16 Xive 4.5 9.5 Simultaneous 3.7  4 S III 12 
  17 Xive 4.5 9.5 Simultaneous 3.6    III 12 
20 56/F 25 Implantium 4.3 10 Simultaneous 4.4  2.5 S II 12 
  26 Implantium 4.3 10 Simultaneous 3.8    II 12 
S: small particle, L: large particle, f/u: follow up. 
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Table 2. Life table analysis. 
Time 
(month) 
Implant at 
risk 
Failure during 
interval 
Interval 
survival (%) 
CSR 
(%) 
0~6 45 2 95.56 95.56 
7~12 43 0 100 95.56 
13~18 32 0 100 95.56 
19~24 18 0 100 95.56 
25~30 6 0 100 95.56 
31~36 1 0 100 95.56 
37~42 1 0 100 95.56 
CSR: cumulative survival rate. 
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Table 3. Radiographic analysis (mean±SD). 
  C/I ratio MBL (mm) RHO (mm) 
  
Time (months) Time (months) 
  0-12 0-42 0-12 0-42 
Mean 1.19 ± 0.24  0.29 ± 0.42 0.52 ± 0.56 0.83 ± 0.38 0.88 ± 0.39 
MBL: marginal bone loss, C/I ratio: crown/implant ratio, RHO: Reduced height 
of Osteon
®
. 
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Table 4. Differences according to the timing of implantation (mean±SD). 
 Simultaneous 
(n=34) 
Delayed (n=11) P value 
(<0.05) 
RHO (mm) 0.80 ± 0.40 0.91 ± 0.30 0.299 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
２５ 
 
Table 5. Differences according to the type of material (mean±SD). 
 S (n=22) S/L (n=23) P value 
(<0.05) 
RHO (mm) 0.81 ± 0.43 0.85 ± 0.33 0.644 
     S: small particle size (0.5-1mm), L: large particle size (1-2mm). 
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Table 6. Differences according to the site of implants (mean±SD). 
 P2 (n=8) M1 (n=22) M2 (n=15) P value 
(<0.05) 
RHO 
(mm) 
0.92 ± 0.42 0.85 ± 0.34 0.75 ± 0.42 0.527 
P2: the 2
nd
 premolar. 
M1: the 1
st
 molar. 
M2: the 2
nd
 molar. 
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Figures 
 
 
 
Figure 1. Scanning electron microscope image of Osteon
®
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Figure 2. Schematic drawing illustrating the linear measurement taken from radiographs. 
(A) Immediately after the sinus augmentation, (B) 1-year after the sinus augmentation. 
MBL: marginal bone loss, C: crown length, I: implant fixture length, OAH(m): mesial 
original alveolar bone height, OAH(d): distal original alveolar bone height, ASH(m): 
mesial augmented sinus height, ASH(d): distal augmented sinus height. 
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국문요약  
 
합성골 이식재인 Osteon®을 이용한 상악동 거상술 -임상적, 방사선 
계측학적 연구 
 
<지도교수 최 성 호> 
연세대학교 대학원 치의학과 
 차  재  국 
 
상악동 거상술을 시행할 때 사용할 골이식재의 선택은 임상가에게 있어서 
고민이 되는 부분이다. 골이식재로서 자가골은 골형성능 및 골유도능을 갖춘 
최상의 골이식재로 평가받지만, 상악동에 적용 시 빠른 흡수 양상을 보인다. 또한 
자가골 채득을 위해 제 2 의 수술부위가 필요한 점, 채취량의 한계로 인해 최근엔 
상악동 골이식재로 합성골의 사용이 대두되는 추세이다. 본 연구에서는 합성골 
이식재인 Osteon®을 단독으로 적용하여 상악동 거상술을 시행한 20 명의 환자, 
45 개의 임플란트를 대상으로 3.5 년의 재내원 기간을 두고 임상적, 방사선 
계측학적 방법을 통해 그 부위의 생존율과 골흡수율을 조사하였다. 방사선학적 
계측은 파노라마 방사선 사진을 이용하였고 결과는 다음과 같다. 1. 임플란트의 
누적 생존율은 95.56 %이다. 2. 모든 환자에서 임상적으로 정상적인 치유과정을 
보였다. 3. 수술 전 치조골의 높이는 평균 4.3 mm 였고, 수술 후 거상된 높이는 
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13.4 mm 였다. 4. 42 개월 까지의 평균 변연골 소실은 0.52±0.56 mm 였다. 5. 
술 후 흡수된 이식재의 양은 0.83±0.38 mm 였고 시간의 흐름에 따른 유의한 
차이를 보이지 않았다 (P=0.102). 6. 이식재의 흡수량은 임플란트 식립 시기나 
이식재의 입자 크기에 따른 유의할만한 차이를 보이지 않았다 (P=0.644). 
이상의 결과를 종합해 볼 때, Osteon®을 상악동 거상술에 적용할 경우, 임상적 
및 방사선학적으로 예견성있게 임플란트의 초기 안정성을 유지할 수 있다. 
아울러 상악동 거상술 후 감염 등과 같은 합병증이 한 건도 발생하지 않았다는 
점에서 단기간의 연구지만 안전하게 쓸 수 있는 재료라고 사료된다. 
 
 
 
 
 
 
 
 
 
 
 
 
 
핵심되는 말: 상악동, 치과 임플란트, 생존율 
